In this line, our data showed that repression of FOXM1 by siRNA in healthy MSC is able to impair the clonogenic potential of CD34 + progenitor cells, in particular for CFU-GM, mirroring the effects observed when using MDS or AML-derived MSC. The gene discussed is CD34; the disease is myelodysplastic syndrome.